rutecarpine has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, JY; Yeh, TH | 1 |
1 other study(ies) available for rutecarpine and Prostatic Neoplasms
| Article | Year |
|---|---|
Rutaecarpine administration inhibits cancer cell growth in allogenic TRAMP-C1 prostate cancer mice correlating with immune balance in vivo.
Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Body Weight; Cachexia; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytokines; Dose-Response Relationship, Drug; Indole Alkaloids; Lymphocyte Count; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Organ Size; Prostatic Neoplasms; Quinazolines; Spleen; Th1-Th2 Balance; Tumor Necrosis Factor-alpha | 2021 |